Cargando…
Pre‐operative risk factors for driveline infection in left ventricular‐assist device patients
AIMS: Implantation of left ventricular‐assist devices (LVAD) to treat end‐stage heart failure is of increasing relevance due to donor shortage. Infections of the driveline are common adverse events. LVAD infections can lead to high urgency listings for transplantation. However, transplantation in pa...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773640/ https://www.ncbi.nlm.nih.gov/pubmed/35997005 http://dx.doi.org/10.1002/ehf2.14112 |
_version_ | 1784855235198451712 |
---|---|
author | Köhler, Ann‐Kristin Körperich, Hermann Morshuis, Michiel Freytag, Claudia Christine Gummert, Jan Burchert, Wolfgang Preuss, Rainer Körfer, Jan |
author_facet | Köhler, Ann‐Kristin Körperich, Hermann Morshuis, Michiel Freytag, Claudia Christine Gummert, Jan Burchert, Wolfgang Preuss, Rainer Körfer, Jan |
author_sort | Köhler, Ann‐Kristin |
collection | PubMed |
description | AIMS: Implantation of left ventricular‐assist devices (LVAD) to treat end‐stage heart failure is of increasing relevance due to donor shortage. Infections of the driveline are common adverse events. LVAD infections can lead to high urgency listings for transplantation. However, transplantation in patients with infection leads to worse post‐transplantation outcomes. This study aims to evaluate specific risk factors for driveline infections at the time of implantation. METHODS AND RESULTS: Four hundred forty‐one patients receiving either Heartmate II or Heartware system from August 2009 to October 2013 were assessed. An expert committee sorted patients into four different groups concerning the likeliness of infection. Twenty‐eight (6%) of discussed infection cases were judged as secured, 33 (7%) as likely, 18 (4%) as possible, and 20 (4%) as unlikely. The remaining 342 (78%) subjects showed either no signs of infection at all times (329 [75%]) or developed signs of infection in a second observation period within 1 year after ending of the first observation period (13 [3%]). For a better discriminatory power, cases of secured and likely infections were tested against the group with no infection at all times in a Cox proportional hazard model. Among all variables tested by univariate analysis (significance level P < 0.15), only age (P = 0.07), LVAD‐type (P = 0.12), need for another thoracic operation (P = 0.02), and serum creatinine value (P = 0.02) reached statistical significance. These were subsequently subjected to multivariate analysis to calculate the cumulative risk of developing a drive infection. The multivariate analysis showed that of all the potential risk factors tested, only the necessity of re‐thoracotomy or secondary thoracic closure had a significant, protective effect (hazard ratio [95% CI] = 0.45 [0.21–0.95]; P = 0.04). CONCLUSION: This single‐centre cohort study shows that driveline infections are common adverse events. The duration of support represents the major risk factor for LVAD driveline infections. |
format | Online Article Text |
id | pubmed-9773640 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97736402022-12-23 Pre‐operative risk factors for driveline infection in left ventricular‐assist device patients Köhler, Ann‐Kristin Körperich, Hermann Morshuis, Michiel Freytag, Claudia Christine Gummert, Jan Burchert, Wolfgang Preuss, Rainer Körfer, Jan ESC Heart Fail Original Articles AIMS: Implantation of left ventricular‐assist devices (LVAD) to treat end‐stage heart failure is of increasing relevance due to donor shortage. Infections of the driveline are common adverse events. LVAD infections can lead to high urgency listings for transplantation. However, transplantation in patients with infection leads to worse post‐transplantation outcomes. This study aims to evaluate specific risk factors for driveline infections at the time of implantation. METHODS AND RESULTS: Four hundred forty‐one patients receiving either Heartmate II or Heartware system from August 2009 to October 2013 were assessed. An expert committee sorted patients into four different groups concerning the likeliness of infection. Twenty‐eight (6%) of discussed infection cases were judged as secured, 33 (7%) as likely, 18 (4%) as possible, and 20 (4%) as unlikely. The remaining 342 (78%) subjects showed either no signs of infection at all times (329 [75%]) or developed signs of infection in a second observation period within 1 year after ending of the first observation period (13 [3%]). For a better discriminatory power, cases of secured and likely infections were tested against the group with no infection at all times in a Cox proportional hazard model. Among all variables tested by univariate analysis (significance level P < 0.15), only age (P = 0.07), LVAD‐type (P = 0.12), need for another thoracic operation (P = 0.02), and serum creatinine value (P = 0.02) reached statistical significance. These were subsequently subjected to multivariate analysis to calculate the cumulative risk of developing a drive infection. The multivariate analysis showed that of all the potential risk factors tested, only the necessity of re‐thoracotomy or secondary thoracic closure had a significant, protective effect (hazard ratio [95% CI] = 0.45 [0.21–0.95]; P = 0.04). CONCLUSION: This single‐centre cohort study shows that driveline infections are common adverse events. The duration of support represents the major risk factor for LVAD driveline infections. John Wiley and Sons Inc. 2022-08-23 /pmc/articles/PMC9773640/ /pubmed/35997005 http://dx.doi.org/10.1002/ehf2.14112 Text en © 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Köhler, Ann‐Kristin Körperich, Hermann Morshuis, Michiel Freytag, Claudia Christine Gummert, Jan Burchert, Wolfgang Preuss, Rainer Körfer, Jan Pre‐operative risk factors for driveline infection in left ventricular‐assist device patients |
title | Pre‐operative risk factors for driveline infection in left ventricular‐assist device patients |
title_full | Pre‐operative risk factors for driveline infection in left ventricular‐assist device patients |
title_fullStr | Pre‐operative risk factors for driveline infection in left ventricular‐assist device patients |
title_full_unstemmed | Pre‐operative risk factors for driveline infection in left ventricular‐assist device patients |
title_short | Pre‐operative risk factors for driveline infection in left ventricular‐assist device patients |
title_sort | pre‐operative risk factors for driveline infection in left ventricular‐assist device patients |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773640/ https://www.ncbi.nlm.nih.gov/pubmed/35997005 http://dx.doi.org/10.1002/ehf2.14112 |
work_keys_str_mv | AT kohlerannkristin preoperativeriskfactorsfordrivelineinfectioninleftventricularassistdevicepatients AT korperichhermann preoperativeriskfactorsfordrivelineinfectioninleftventricularassistdevicepatients AT morshuismichiel preoperativeriskfactorsfordrivelineinfectioninleftventricularassistdevicepatients AT freytagclaudiachristine preoperativeriskfactorsfordrivelineinfectioninleftventricularassistdevicepatients AT gummertjan preoperativeriskfactorsfordrivelineinfectioninleftventricularassistdevicepatients AT burchertwolfgang preoperativeriskfactorsfordrivelineinfectioninleftventricularassistdevicepatients AT preussrainer preoperativeriskfactorsfordrivelineinfectioninleftventricularassistdevicepatients AT korferjan preoperativeriskfactorsfordrivelineinfectioninleftventricularassistdevicepatients |